Skip to main content

Food Allergy News and Research

Clinical Trial Will Test Whether Omalizumab Can Reduce Food Allergy Reactions

While experimental desensitization strategies are available in research settings, people with food allergies must avoid known allergens and are advised to carry injectable epinephrine to prevent potentially life-threatening allergic reactions caused by accidental exposures. To help alleviate this risk, a new study to evaluate an experimental treatment for food allergy launched today.

New California Law: the Natalie Giorgi Sunshine Act Requires Food Allergy Training for All Food Handlers

Governor Newsom has signed the Natalie Giorgi Sunshine Act. This bill was authored by Assemblymember Rebecca Bauer-Kahan (AD16 D-Orinda) and named in honor of Natalie Giorgi. Natalie passed away at age 13 due to a severe allergic reaction to undeclared peanut in a treat while at a summer camp in Sacramento. AB 1532 requires all food handlers to have a simple certification in safe food handling practices for major food allergens. This bill also would add “Organized Camps” to the definition of...

Facebook Live: New Food Allergy Treatments

Join Dr. Katie Freidman of Forever Freckled and Kenny Mendez, President and CEO of the Asthma and Allergy Foundation of America (AAFA) and Kids With Food Allergies, a division of AAFA, for a Facebook Live discussion around what parents need to know about new treatments for kids with food allergies, in particular, peanut allergy. Thursday, July 25, 2019, at 1:30 – 2 pm ET.

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.

Walgreens to Now Carry Kaléo AUVI-q 0.1 mg Epinephrine Auto-Injectors for Infants and Toddlers

Walgreens and kaléo, a privately-held pharmaceutical company, today announced AUVI-q® (epinephrine injection, USP) 0.1 mg auto-injector is available at Walgreens locations nationwide. AUVI-q 0.1 mg is the first and only epinephrine auto-injector (EAI) approved by the U.S. Food and Drug Administration (FDA) for infants and toddlers weighing 16.5 to 33 pounds (7.5 to 15 kilograms). Through this collaboration, Walgreens is the first national retail pharmacy to offer the entire AUVI-Q auto-injector

Asthma and Allergy Foundation of America Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).

FDA Extends Expiration Dates of All Lots of EpiPens® and Authorized Generic

As supply interruptions and shortages of epinephrine auto-injectors continue, the FDA has extended the expiration dates of all lots of EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors and its authorized generic version currently on the market in the U.S. after a review of stability data. Read more for the new expiration dates.

Court Ruling Favors People With Food Allergies, Gluten Sensitivity and Celiac Disease

J.D.'s family sued Colonial Williamsburg based on discrimination against someone with a disability. On May 31, 2019, the U.S. Court of Appeals of the Fourth Circuit ruled in favor of J.D. and his family. This ruling impacts people with food allergies, celiac disease and non-celiac gluten sensitivity. Allowing people to bring in safe food into a public place may be a necessary and reasonable accommodation. Food allergies are a disability under that Americans With Disabilities Act (ADA).

The Social and Emotional Impact of Food Allergies

Kids With Food Allergies (KFA) conducted the My Kid's Life With Food Allergies survey in April 2019. We surveyed 1,234 parents of children with food allergies to capture more information about the full impact of food allergies on families' lives – including the social and emotional burden of managing this chronic disease.

Post
Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
1235 South Clark Street Suite 305, Arlington, VA 22202
Phone: 1-800-7-ASTHMA (1.800.727.8462)
-->
×
×
×
×